Author

B. K. Jang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Organism:non-human primate· 1

Frequent Co-Authors

C. J. Lee· 1 shared D.-W. Cho· 1 shared H. H. Yoon· 1 shared H. J. Song· 1 shared J. W. Choi· 1 shared J. Y. Heo· 1 shared J.-H. Park· 1 shared K. D. Park· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. J. Lee

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

KDS2010, a newly developed reversible MAO-B inhibitor, as an effective therapeutic candidate for Parkinson's disease

M.-H. Nam, J.-H. Park, H. J. Song, J. W. Choi, S. Kim, B. K. Jang, H. H. Yoon, J. Y. Heo, D.-W. Cho, Y.-S. Yang, S.-C. Han, S. Kim, S.-J. Oh, S. R. Jeon, K. D. Park, C. J. Lee

This paper tests KDS2010, a reversible MAO-B inhibitor, in PD animal models and finds it effective with low toxicity and superior neuroprotection compared to selegiline.

bioRxiv · Jul 6, 2020Pharmacology & Toxicology